Tryptamine Therapeutics

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In

Tryptamine Therapeutics listed in 2024 through the reverse takeover of Exopharm. Tryptamine Therapeutics is a clinical-stage biotechnology company focused on the development of an IV infusion of psilocin (the active metabolite of psilocybin) which addresses many of the current limitations associated with orally administered psilocybin used by the majority of competitors in the field. Tryp’s lead programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy.

Contact Details

C/o Bio101 Financial Advisory Pty Ltd Suite 201 , 697 Burke Road CAMBERWELL VIC 3124
tryptherapeutics.com

Lists and Charts

Share price

Tryptamine Therapeutics
Closing price for the last 90 trading days
View ASX Chart
Powered by Morningstar ®

Total Shareholder Return as at 02/12/24

Rank Company 1 Yr 5 Yr
26th Gryphon Minerals 318.25% -30.9%
27th WIA Gold 313.41% 30.96%
28th Tryptamine Therapeutics 301.01% -33.98%
29th Peak Minerals 300% -12.94%
30th Richfield International 295.29% 57.58%
View Full List
1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Company Share Transactions

02/12/24
Issued
Tryptamine Therapeutics
02/12/24
Issued
Tryptamine Therapeutics
01/12/23
Issued
Tryptamine Therapeutics
Total value as at the date of the transaction
Powered by Morningstar ®

Company Activity

 NEW ROLE: Jim Gilligan, 02 Dec 2024
NEW ROLE: Jim O'Neill, 02 Dec 2024
Chris Ntoumenopoulos
NEW ROLE: Chris Ntoumenopoulos, Non-Executive Director 08 Aug 2024
Mark Davies
NEW ROLE: Mark Davies, Non-Executive Chairman, Non-Executive Director 08 Aug 2024
UPDATED: Public Companies - non WA list 05 Jul 2024
Clarke Barlow
NEW ROLE: Clarke Barlow, Non-Executive Director 17 Nov 2023
RANKING: 918 Down from 701 in Public Companies - non WA list 02 Oct 2023

News Articles

Related Information

Access to our data for Tryptamine Therapeutics is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Tryptamine Therapeutics is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today

X